Showing 2121-2130 of 2314 results for "".
- SIFI Provides Italian Hospital Products to Treat Ocular Discomfort and Prevent Potential Risks of Infectionhttps://modernod.com/news/sifi-provides-italian-hospital-products-to-treat-ocular-discomfort-and-prevent-potential-risks-of-infection/2477436/Italian ophthalmic pharmaceutical company SIFI is donating multiple products to the ophthalmology departments of the main Italian hospitals, including sterile products for the treatment of ocular discomfort and for the prevention of potential risks of infection. As seen in the COVID-19 Gui
- Novartis, Mylan and Teva to Supply Tens of Millions of Chloroquine Tablets to Fight COVID-19https://modernod.com/news/novartis-mylan-and-teva-to-supply-tens-of-millions-of-chloroquine-tablets-to-fight-covid-19/2477430/As efforts to discover new COVID-19 medicines roll on, President Donald Trump and others this week focused attention on the decades-old malaria drug chloroquine. Bayer got things rolling with an initial donation of the drug, and now Novartis, Mylan and Teva are takin
- Facing the COVID-19 Threat, More Optical Retailers and ECPs Make the Tough Decision to Temporarily Close Locations or Modify Serviceshttps://modernod.com/news/facing-the-covid-19-threat-more-optical-retailers-and-ecps-make-the-tough-decision-to-temporarily-close-locations-or-modify-services/2477420/As the impact and spread of the coronavirus pervades much of the U.S., several more major regional and national optical retailers and eyecare practices have made the difficult decision to close their doors temporarily or modify their hours and services to customers and patients, according to a Vi
- Topcon Announces Customer Initiatives to Combat Global COVID-19 Crisishttps://modernod.com/news/topcon-announces-customer-initiatives-to-combat-global-covid-19-crisis/2477421/As the COVID-19 pandemic continues to escalate across the globe, Topcon Healthcare has announced a series of initiatives and programs designed to support its customers during this time of unprecedented challenges. As healthcare providers, eye doctors are required to be in close contact wit
- Trump Touts Drug That FDA Says Isn’t Yet Approved for Virushttps://modernod.com/news/trump-touts-drug-that-fda-says-isnt-yet-approved-for-virus/2477422/The Food and Drug Administration has been told by President Donald Trump to see if it can expand the use of a decades-old malaria drug as an experimental treatment for coronavirus patients, as
- Roche Initiates Phase 3 Trial of Actemra/RoActemra in Patients With Severe COVID-19 Pneumoniahttps://modernod.com/news/roche-initiates-phase-3-trial-of-actemra-roactemra-in-patients-with-severe-covid-19-pneumonia/2477410/Roche announced it is working with the FDA to initiate a randomized, double-blind, placebo-controlled phase 3 clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), a part of the US Health and Human Services Office of th
- Acuity Eye Group Offers Tips During National Nutrition Month For Better Visionhttps://modernod.com/news/acuity-eye-group-offers-tips-during-national-nutrition-month-for-better-vision/2477373/More and more evidence is showing that diet has an impact on every aspect of ones health, including vision. In honor of National Nutrition Month, doctors at Acuity Eye Group have tips and recommendations to eat your way to better vision. Research shows that a healthy diet and lifestyle wit
- Analysts Give Gilead’s Remdesivir 50% Chance of Success as COVID-19 Treatmenthttps://modernod.com/news/analysts-give-gileads-remdesivir-50-chance-of-success-as-covid-19-treatment/2477362/Analysts at RBC Capital Markets suggested that it is a toss-up whether Gilead Sciences’ remdesivir will succeed in demonstrating efficacy and ultimately securing approval to treat COVID-19, citing limited dosing results, confounding data and previous disappointments in Ebola. “[The] b
- Eyevance Pharmaceuticals launches Tobradex ST in the United Stateshttps://modernod.com/news/eyevance-pharmaceuticals-launches-tobradex-st-in-the-united-states/2477333/Eyevance Pharmaceuticals has announced the US launch of Tobradex ST (tobramycin/dexamethasone ophthalmic suspension) 0.3%/0.05% following the company’s acquisition of the product in late 2019. Tobradex ST is an FDA approved, fixed-dose topical antibiotic and corticosteroid combination indicated f
- The American Optometric Association (AOA) Partners With Lyft To Offer Free Rides To Get A Comprehensive Eye Examhttps://modernod.com/news/the-american-optometric-association-aoa-partners-with-lyft-to-offer-free-rides-to-get-a-comprehensive-eye-exam/2477334/The American Optometric Association (AOA), the leading authority on quality care and an advocate for our nation’s health, representing more than 30,000 doctors of optometry, announced that it is working with Lyft, the transportation network, to offer free rides to people in select cities in
